Tyler Morad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tyler Morad has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Geoffrey W. Cho
National Institute for Cardiovascular Research and Innovation niCVRI (Formerly CVRF Southern California) Beverly Hills, CA, USA; David Geffen School of Medicine, Division of Cardiology, University of California Los Angeles, Los Angeles, CA, USA
2 shared publications - Abhinav R. Thummala
David Geffen School of Medicine, Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA
1 shared publication - Francisco X. Elisarraras
University of California-Los Angeles Health, Los Angeles, California, USA
1 shared publication - Ilana Golub
David Geffen School of Medicine, Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA
1 shared publication - Jasmeet S. Dhaliwal
David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA
1 shared publication - Michael A. Raddatz
University of California, Los Angeles, Los Angeles, California, UNITED STATES
1 shared publication
Latest Publications
- Open Access
- 1 July 2026
- Published by American College of Physicians in Annals of Internal Medicine: Clinical Cases
- Vol. 5 (7)
Recurrent Sinus Arrests With Lumbar Drain Manipulation
Increased intracranial pressure causing vagally triggered sinus bradycardia has been well described as part of the Cushing reflex. Here, we present a case of a Cushing-like reflex in which a patien...
- 1 July 2026
- Published by American College of Physicians in Annals of Internal Medicine: Clinical Cases
- Vol. 5 (7)
Open AccessRecurrent Sinus Arrests With Lumbar Drain Manipulation
Increased intracranial pressure causing vagally triggered sinus bradycardia has been well described as part of the Cushing reflex. Here, we present a case of a Cushing-like reflex in which a patien...
- Open Access
- 19 March 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (6) , 2095
Artificial Intelligence in Nuclear Cardiac Imaging: Novel Advances, Emerging Techniques, and Recent Clinical Trials
Cardiovascular disease (CVD) is a leading cause of death, accounting for over 30% of annual global fatalities. Ischemic heart disease, in turn, is a frontrunner of worldwide CVD mortality. With the burden of coronary disease rapidly growing, understanding the nuances of cardiac imaging and risk prognostication becomes paramount. Myocardial perfusion imaging (MPI) is a frequently utilized and well established testing modality due to its significant clinical impact in disease diagnosis and risk assessment. Recently, nuclear cardiology has witnessed major advancements, driven by innovations in novel imaging technologies and improved understanding of cardiovascular pathophysiology. Applications of artificial intelligence (AI) to MPI have enhanced diagnostic accuracy, risk stratification, and therapeutic decision-making in patients with coronary artery disease (CAD). AI techniques such as machine learning (ML) and deep learning (DL) neural networks offer new interpretations of immense data fields, acquired through cardiovascular imaging modalities such as nuclear medicine (NM). Recently, AI algorithms have been employed to enhance image reconstruction, reduce noise, and assist in the interpretation of complex datasets. The rise of AI in nuclear medicine (AI-NM) has proven itself groundbreaking in the efficiency of image acquisition, post-processing time, diagnostic ability, consistency, and even in risk-stratification and outcome prognostication. To that end, this narrative review will explore these latest advances in AI in nuclear medicine and its rapid transformation of the cardiac diagnostics landscape. This paper will examine the evolution of AI-NM, review novel AI techniques and applications in nuclear cardiac imaging, summarize recent AI-NM clinical trials, and explore the technical and clinical challenges in its implementation of artificial intelligence.
- 19 March 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (6) , 2095
Open AccessArtificial Intelligence in Nuclear Cardiac Imaging: Novel Advances, Emerging Techniques, and Recent Clinical Trials
Cardiovascular disease (CVD) is a leading cause of death, accounting for over 30% of annual global fatalities. Ischemic heart disease, in turn, is a frontrunner of worldwide CVD mortality. With the burden of coronary disease rapidly growing, understanding the nuances of cardiac imaging and risk prognostication becomes paramount. Myocardial perfusion imaging (MPI) is a frequently utilized and well established testing modality due to its significant clinical impact in disease diagnosis and risk assessment. Recently, nuclear cardiology has witnessed major advancements, driven by innovations in novel imaging technologies and improved understanding of cardiovascular pathophysiology. Applications of artificial intelligence (AI) to MPI have enhanced diagnostic accuracy, risk stratification, and therapeutic decision-making in patients with coronary artery disease (CAD). AI techniques such as machine learning (ML) and deep learning (DL) neural networks offer new interpretations of immense data fields, acquired through cardiovascular imaging modalities such as nuclear medicine (NM). Recently, AI algorithms have been employed to enhance image reconstruction, reduce noise, and assist in the interpretation of complex datasets. The rise of AI in nuclear medicine (AI-NM) has proven itself groundbreaking in the efficiency of image acquisition, post-processing time, diagnostic ability, consistency, and even in risk-stratification and outcome prognostication. To that end, this narrative review will explore these latest advances in AI in nuclear medicine and its rapid transformation of the cardiac diagnostics landscape. This paper will examine the evolution of AI-NM, review novel AI techniques and applications in nuclear cardiac imaging, summarize recent AI-NM clinical trials, and explore the technical and clinical challenges in its implementation of artificial intelligence.